News

Varenicline helps smokers with stably treated depression

View on the News

Trial may be helpful in understanding of non-psychiatrically ill smokers with history of depression

Dr. Vera DePalo

Dr. Vera DePalo, FCCP, comments: Smoking is a habit that contributes to several disease states and many strategies are employed to help with smoking cessation. Practitioners continue to search for the intervention that can aid the patient in success. As with all pharmacologic therapies,the prescriber considers the unintended side effects.
This industry-funded trial may be helpful to the practitioner's understanding of the possible options in non-psychiatrically ill smokers with a history of depression.


 

FROM ANNALS OF INTERNAL MEDICINE

*CORRECTION, 10/10/13: An earlier version of this article misstated the citation for the journal article referenced in the story.

Pages

Recommended Reading

Exercise Reaps Double Benefits in Post-MI Depression
MDedge Cardiology
Three Weight-Loss Diets Yield Three Metabolic Effects
MDedge Cardiology
Tailored Weight-Loss Programs May Save Money
MDedge Cardiology
Exercise Cuts Depressive Symptoms in Heart Failure Patients
MDedge Cardiology
Exercise Rivals Sertraline in Comorbid CHD, Depression
MDedge Cardiology
Heart Failure Hospitalization, Deaths Decline with Depression Intervention
MDedge Cardiology
Depressed stroke survivors at increased risk of death
MDedge Cardiology
More insulin resistance, metabolic syndrome with PTSD
MDedge Cardiology
Link between depression, medical comorbidities underscores need for screening
MDedge Cardiology
Antidepressant-induced cardioprotection after event reverses with a vengeance
MDedge Cardiology